Largest biotech companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 20 biotech companies in the United States ranked by earnings, at SEK 86.9B, ahead of Amgen (SEK 78.7B) and Biogen (SEK 13.2B). Figures as of 20 Nov 2026, 14:44 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Gilead SciencesSEK 86.9B
- Median
- -SEK 700M
- Combined market value
- SEK 7.59T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SEK 86.9B | SEK 2.14T | SEK 1,727.11 | 1.62% up | 31% up | ||
| 2 | AmgenAMGN · Health Care | SEK 78.7B | SEK 2.44T | SEK 4,513.99 | 1.38% up | 30% up | ||
| 3 | BiogenBIIB · Health Care | SEK 13.2B | SEK 376.3B | SEK 2,545.66 | 0.93% up | 41% up | ||
| 4 | ExelixisEXEL · Health Care | SEK 8B | SEK 165.5B | SEK 678.38 | 0.97% up | 55% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | SEK 4.9B | SEK 162.4B | SEK 1,604.64 | 0.41% up | 10% up | ||
| 6 | Halozyme TherapeuticsHALO · Health Care | SEK 3.2B | SEK 108.1B | SEK 948.47 | 0.11% down | 32% up | ||
| 7 | Krystal BiotechKRYS · Health Care | SEK 2.1B | SEK 97.1B | SEK 3,276.03 | 1.64% up | 49% up | ||
| 8 | Bio-TechneTECH · Health Care | SEK 1.9B | SEK 116.6B | SEK 742.21 | 0.03% up | 18% up | ||
| 9 | RepligenRGEN · Health Care | SEK 499M | SEK 109.9B | SEK 1,718.87 | 1.10% down | 5% up | ||
| 10 | Adaptive BiotechnologiesADPT · Health Care | -SEK 607.2M | SEK 46.4B | SEK 286.63 | 0.12% up | 51% up | ||
| 11 | Twist BioscienceTWST · Health Care | -SEK 792.7M | SEK 72B | SEK 1,055.47 | 7.35% down | 291% up | ||
| 12 | CG OncologyCGON · Health Care | -SEK 1.6B | SEK 74.3B | SEK 832.12 | 0.45% down | 93% up | ||
| 13 | Kodiak SciencesKOD · Health Care | -SEK 2.3B | SEK 64.9B | SEK 992.61 | 0.65% down | 371% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | -SEK 3.2B | SEK 103.4B | SEK 1,210.99 | 0.61% down | 81% up | ||
| 15 | ImmunityBioIBRX · Health Care | -SEK 3.6B | SEK 70B | SEK 65.83 | 1.83% down | 216% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | -SEK 3.9B | SEK 63.1B | SEK 517.38 | 0.65% up | 25% up | ||
| 17 | ImmunovantIMVT · Health Care | -SEK 5.2B | SEK 68.5B | SEK 330.77 | 0.34% down | 44% up | ||
| 18 | VaxcytePCVX · Health Care | -SEK 7.8B | SEK 93.1B | SEK 587.95 | 1.29% down | 22% up | ||
| 19 | Revolution MedicinesRVMD · Health Care | -SEK 11.5B | SEK 365.1B | SEK 1,687.82 | 3.73% up | 125% up | ||
| 20 | ModernaMRNA · Health Care | -SEK 28.8B | SEK 847.8B | SEK 2,095.33 | 3.00% up | 740% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2057 SEK).
Questions and answers
Which biotech companies in the United States rank first by earnings?
Gilead Sciences (SEK 86.9B), Amgen (SEK 78.7B) and Biogen (SEK 13.2B) are the top three of the 20 biotech companies in the United States ranked by earnings as of 20 Nov 2026, 14:44 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by earnings.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by earnings have a combined market value of SEK 7.59T as of 20 Nov 2026, 14:44 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.